01.002 RWE KR Apr 2022 E 28-04-2022

Treating cancer with messenger RNA (mRNA) vaccines

  • mRNA vaccines have emerged more recently and have been headlined with the Pfizer-BioNTech and Moderna vaccines for COVID-19.
  • Knowing exactly which mutations an individual’s cancer carries could allow scientists to develop mRNA vaccines specific to their particular cancer. Customising treatment in this way, whether for cancer or other diseases, is known as personalised medicine.
  • “The great thing about mRNA vaccines are the manufacturing, scalability, and cost,”

Dr. Kesari

Director of Neuro-oncology at Pacific Neuroscience Institute

Click here to learn more.

About SVMPharma

SVMPharma is an innovative strategic consultancy and CRO, with a focus in Real World Evidence (RWE) for pharmaceutical and biotechnology companies. SVMPharma delivers clinical trials within UK and Europe.


DISTILL is a new EDC launched by SVMPharma. As a CRO discover the benefits of DISTILL as part of your service offering and take back control of your clinical trials. DISTILL allows you to develop and manage every aspect of your trials from start to finish. Move away from the restrictions and costs associated with legacy systems.

For more information, please visit and contact us at